OGEN

Oragenics (OGEN)

About Oragenics (OGEN)

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Details

Daily high

$0.44

Daily low

$0.40

Price at open

$0.43

52 Week High

$7.74

52 Week Low

$0.25

Market cap

5.7M

Dividend yield

0.00%

Volume

165,297

Avg. volume

1.4M

P/E ratio

-.08

Oragenics News